Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-12-03

Clinical Trial Update: Efficacy and Safety of Tixel Treatment on Facial and/or Scalp Actinic Keratoses. [NA]

View source ↗

Summary

A completed clinical trial evaluating the efficacy and safety of the Tixel treatment for facial and scalp actinic keratoses; results were posted on 2024-12-03.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Tixel

Snippet

Sponsor: Novoxel Ltd. | Conditions: Actinic Keratoses | NA | Status: COMPLETED | Results posted: 2024-12-03